These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 13283753)
41. Serological aspects of the placenta and other organs in the hemolytic diseases of the newborn caused by Rhesus antagonism. van BOLHUIS JH Maandschr Kindergeneeskd; 1950; 18(3/4):106-14. PubMed ID: 15438067 [No Abstract] [Full Text] [Related]
42. [ABO ANTAGONISM BETWEEN MOTHER AND CHILD AS A PROTECTIVE MECHANISM IN RHESUS FACTOR SENSITIZATION]. HERLYN U; GALLASCH E; GELLER HF Geburtshilfe Frauenheilkd; 1964 Dec; 24():1053-60. PubMed ID: 14304799 [No Abstract] [Full Text] [Related]
43. The Rh factor: practical considerations. VAUGHAN VC Conn State Med J; 1950 Dec; 14(12):1089-93. PubMed ID: 14792959 [No Abstract] [Full Text] [Related]
44. [Clinical features, serology and pathogenesis of erythroblastosis in newborn of diabetic mother]. FULLING G; LODENKAMPER H Z Kinderheilkd; 1953; 73(2):174-87. PubMed ID: 13103373 [No Abstract] [Full Text] [Related]
45. [A and B antigens isoimmunization in pregnancy and hemolytic disease in newborn]. GROULADE J; FINE J Sang; 1953; 24(6):513-25. PubMed ID: 13101608 [No Abstract] [Full Text] [Related]
46. Combined Rh and AB hemolytic disease of the newborn. GUNSON HH Am J Clin Pathol; 1957 Jan; 27(1):35-41. PubMed ID: 13410834 [No Abstract] [Full Text] [Related]
47. [Contribution to the histology of erythroblastosis due to the Rh factor]. PUIGGROS SALA J Arch Esp Morfol; 1951; 9(32):83-90. PubMed ID: 12987152 [No Abstract] [Full Text] [Related]
48. [NEW CONTRIBUTION TO THE STUDY OF THE DETERMINATION OF THE BLOOD GROUP OF THE FETUS IN UTERO]. DUCOS J; MARTY Y Bibl Haematol; 1964; 19():244-50. PubMed ID: 14267006 [No Abstract] [Full Text] [Related]
49. A case of fetoplacentar edema. VANDEPITTE J; VAN MEERBEECK P Ann Soc Belg Med Trop (1920); 1952 Dec; 32(5):539-42. PubMed ID: 13031308 [No Abstract] [Full Text] [Related]
51. [ATTEMPTS AT PREVENTING THE SENSITIZATION OF RH-NEGATIVE WOMEN BY ANTIBODY-CONTAINING SERA]. PREISLER O; SCHNEIDER J Geburtshilfe Frauenheilkd; 1964 Feb; 24():124-31. PubMed ID: 14149861 [No Abstract] [Full Text] [Related]
52. [Prevention of fetal erythroblastosis in pregnancy]. JOSEF C Cesk Gynekol; 1950; 15(4-5):353-64. PubMed ID: 15434864 [No Abstract] [Full Text] [Related]
53. [Contribution to the early diagnosis of erythroblastosis fetal by Rh factor]. POHL J Dtsch Gesundheitsw; 1953 Mar; 8(10):304-5. PubMed ID: 13067751 [No Abstract] [Full Text] [Related]
54. [Posttransfusion immunization due to subgroups of the Rh factor. Advisability of induced labor]. ANDRE A; BARZIN P; BOVENISTY J; LEGROS J Brux Med; 1959 Sep; 39():1207-13. PubMed ID: 13793497 [No Abstract] [Full Text] [Related]
55. The morbid anatomy of erythroblastosis fetalis and its relation to the Rh-factor. RANSTROM S Acta Paediatr (Stockh); 1951 Jan; 40(1):41-58. PubMed ID: 14818806 [No Abstract] [Full Text] [Related]
56. Iso-immunization by rare Rh-antigens as a cause of haemolytic disease of the newborn and transfusion reactions. VAN LOGHEM JJ; HART MV J Clin Pathol; 1949 Nov; 2(4):284-8. PubMed ID: 15396427 [No Abstract] [Full Text] [Related]
57. [PLACE OF IMMUNE TOLERANCE AND ANTIGEN COMPETITION IN MATERNAL ISO-IMMUNIZATION TO THE RHESUS FACTOR]. SEIGNEURIN R; DUBORGEL S; MAGNIN R Presse Med (1893); 1964 Jun; 72():1649-52. PubMed ID: 14151510 [No Abstract] [Full Text] [Related]
58. [Clinical, hematologic and serologic phenomena in the newborn affected by hemolytic disease due to Rh antagonism of the parents]. SOETERS JM Rev Hematol; 1950; 5(3-4):462-5. PubMed ID: 15441588 [No Abstract] [Full Text] [Related]
60. Erythroblastosis fetalis caused by immunization with the agglutinogens of the major blood groups; report of a case. STOKES GH Jefferson-Hillman Hosp Bull; 1948 Oct; 2(4):147-9. PubMed ID: 18101954 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]